BSH works with selected industry partners to support our charitable objectives and deliver value for the haematology community.
Our partnerships help us provide education, encourage professional development and create opportunities for constructive dialogue across the specialty.
All partnerships are managed in line with BSH’s governance processes and relevant industry compliance requirements. BSH retains full independence over its strategy, policies, educational content and professional standards.
BSH is pleased to welcome Johnson & Johnson as an Industry Partner for 2026–2027
Through this partnership, BSH and Johnson & Johnson will work together to support education, professional development, learning and engagement across the UK haematology community, with a shared ambition to support progress across the specialty.
Johnson & Johnson focuses on areas of haematology where patient needs are high and its scientific expertise is deep, including multiple myeloma and B-cell malignancies. Its partnership with BSH builds on Johnson & Johnson’s commitments to innovation in blood cancer and to helping create the conditions for scientific advances to translate into better, more equitable outcomes for patients.
Our approach to industry partnerships
Industry partnerships help BSH connect with organisations that share an interest in supporting the haematology community.
Our partnerships are intended to
- Support high-quality education
- Encourage professional and career development
- Facilitate appropriate discussion of emerging priorities
- Help connect the profession with wider stakeholders
- Support activities that benefit haematology professionals and patients
BSH maintains responsibility for its strategy, educational programme, policies and professional outputs.
Engagement with industry partners is conducted within BSH’s governance framework and relevant industry compliance requirements.